You are viewing the site in preview mode

Skip to main content

Table 3 Reduction of attacks ≥ 50% after 3 weeks in 44 patients with cluster headache

From: Cluster headache and galcanezumab: the first real-world Brazilian study and an expert consensus on its use among other treatments

Form

Galcanezumab

Verapamil

(episodic = 7)

(chronic = 4)

Lithium

(episodic = 2)

(chronic = 2)

240 mg

(episodic = 8)

(chronic = 0)

300 mg

(episodic = 27)

(chronic = 2)

360 mg

(episodic = 2)

(chronic = 5)

Episodic (n; %)

4 (50.0)

20 (74.0)

2 (100.0)

5 (71.0)

2 (100.0)

Chronic n; %)

0 (0.0)

1 (50.0)

2 (40.0)

2 (50.0)

1 (50.0)